13th Annual Fall Midwest Thoracic and GI Oncology Conference

 

13th Annual Fall Midwest Thoracic and GI Oncology Conference
Avatar

Targeting EGFR in NSCLC: Osimertinib, What is the Best TKI Upfront and Combination of EGFR +IO

By 13th Annual Fall Midwest Thoracic and GI Oncology Conference FEATURING Vinicius Ernani
By 13th Annual Fall Midwest Thoracic and GI Oncology Conference FEATURING Vinicius Ernani
546 views
December 19, 2018
0 Comments
Login to view comments. Click here to Login

Featured Video

10:25
Exelixis

Explore the mechanism of Action of a TKI in HCC

Feat. W. Keiser

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam
Lung
40:51
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Lung Cancer in Former Smokers

Feat. M. Kessinger
36:16
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Immunotherapy for Metastatic NSCLC - Immunity Mechanisms, Anti-PD1/P…

Feat. M. Patel
17:31
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Current Issues and Potential Future Applications of Radiation Therap…

Feat. C. Zhang
20:02
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Immunomodulation from Local Radio Therapy in Lung Cancer

Feat. C. Zhang
23:01
13th Annual Fall Midwest Thoracic and GI Oncology Conference

How to Manage Relapsed SCLC & data from ImPower: Result of Atezo…

Feat. A. Ganti
15:10
13th Annual Fall Midwest Thoracic and GI Oncology Conference

NSCLC Practical Tips in Management of Immunotherapy Side Effects on …

Feat. J. Hurley
23:18
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Management of Ground-Glass Opacity Lesions in Lung Cancer

Feat. K. Trujillo
14:03
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Targeting EGFR in NSCLC: Osimertinib, What is the Best TKI Upfront a…

Feat. V. Ernani
17:25
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Targeting ALK in NSCLC: Alectinib 1st Line Treatment Choice, New Pro…

Feat. V. Ernani
14:35
13th Annual Fall Midwest Thoracic and GI Oncology Conference

NSCLC Updated Molecular Testing Guidelines for 2018

Feat. J. Cox
14:20
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Molecular Testing Genes in NSCLC, Emerging Markers and Next Generati…

Feat. J. Cox
18:26
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Immunotherapy in Early Stage NSCLC and PACIFIC Trial of Durvalumab i…

Feat. A. Marr
12:43
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Is There Any Role of Immunotherapy in NSCLC Stage 1 & Stage 2?

Feat. A. Marr
14:11
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Brief History of Robotics in Surgery

Feat. D. Berkheim
07:45
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Robotic Assisted Thymectomy

Feat. D. Berkheim
18:11
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Robotic Assisted Lobectomy

Feat. D. Berkheim
10:58
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Radiology - What Does Ground Glass/Sub-Solid Mean?

Feat. M. DeVries
24:18
13th Annual Fall Midwest Thoracic and GI Oncology Conference

What Processes Can Use Ground Glass and How That Relates to Small Ad…

Feat. W. West
13:06
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Current Recommendations for Follow Up/Management of Sub-Solid Nodules

Feat. M. DeVries
05:55
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Ground Glass/Sub-Solid Nodules Q&A

Feat. W. West, M. DeVries